Answers are grounded in this paper and cite their sources.
This review highlights how gut microbiota affects immune responses in cancer treatments, suggesting microbiota-based strategies may enhance immunotherapy.
The gut microbiota significantly influences cancer immunotherapy efficacy by modulating immune responses, remodeling the tumor microenvironment (TME), and producing key metabolites. Strategies such as FMT, probiotics, and dietary interventions show promise in enhancing responses to ICIs and ACTs while reducing immune-related adverse events (irAEs). This review summarizes clinical and preclinical findings and discusses microbiota-based interventions and future directions for precision immunotherapy.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: